Guardant Health, Inc. (GH) — Stock Score Summary

Guardant Health, Inc. (GH) has a MoatMap StockRank of 76/100 based on Quality (38/100), Value (49/100), and Momentum (70/100) factor scores. The current signal is BUY. Guardant Health is a leader in liquid biopsy and precision oncology. While it has high growth potential, it remains unprofitable with high cash burn, failing the Terry Smith and Warren Buffett lenses of high ROIC and positive owner earnings.

Guardant Health, Inc. is a leading precision oncology company specializing in advanced liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection. Its competitive advantage stems from proprietary genomic profiling technology, extensive clinical validation, and a strong market position as a pioneer in non-invasive cancer diagnostics. The company collaborates with pharmaceutical partners to accelerate precision medicine in oncology.

Key Financial Metrics

Price$127.03
Market Cap$17.7B
P/E (Forward)-229.29
Price/Book-96.63
Return on Invested Capital-24.2%
Gross Margin64.9%
Operating Margin-40.2%
Revenue Growth48.3%
Free Cash Flow$-85M

Guardant Health, Inc. operates in the Diagnostics & Research industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Guardant Health, Inc.’s (GH) StockRank?
MoatMap’s StockRank for Guardant Health, Inc. (GH) is 76/100, with a Buy signal. It is a composite of Quality (38), Value (49), and Momentum (70) factor ranks across MoatMap’s 19,000+ stock universe.
Does Guardant Health, Inc. have an economic moat?
Guardant Health, Inc. (GH) has a Quality factor score of 38/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Guardant Health, Inc. a buy, hold, or sell?
MoatMap’s current signal for Guardant Health, Inc. (GH) is Buy, based on a StockRank of 76/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Guardant Health, Inc. in?
Guardant Health, Inc. (GH) operates in the Healthcare sector, specifically the Diagnostics & Research industry (United States).
Browse all ranked stocksGH deep dive reportAI ChampionsHow we score stocksSense-check another stock